Showing results (521-530 of 901) with videos related to

Sort By:
Pageof 91
NPJ Digital Medicine|January 16, 2026
Towards interpretable prediction of recurrence risk in breast cancer using pathology foundation modelsJakub R Kaczmarzyk, Sarah C Van Alsten, Alyssa J Cozzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 15, 2002
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecanS Sharma, N Kemeny, D P Kelsen, et al.
Clinical Colorectal Cancer|February 7, 2022
Simplified Graded Infusion Strategy for Mitigation of Oxaliplatin HypersensitivitySalvador Alonso Martinez, Neil H Segal, Andrea Cercek, et al.
European Journal of Cancer (Oxford, England : 1990)|January 25, 2011
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803D Sargent, Q Shi, G Yothers, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2002
Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancerN Kemeny, W Tong, M Gonen, et al.
Journal of Pathology Informatics|December 25, 2024
Prioritizing cases from a multi-institutional cohort for a dataset of pathologist annotationsVictor Garcia, Emma Gardecki, Stephanie Jou, et al.
The Oncologist|July 9, 2011
KRAS and colorectal cancer: ethical and pragmatic issues in effecting real-time change in oncology clinical trials and practiceCharles D Blanke, Richard M Goldberg, Axel Grothey, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 1993
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancerB D Minsky, A M Cohen, N Kemeny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2020
Phase I Study of Trifluridine/Tipiracil Plus Irinotecan and Bevacizumab in Advanced Gastrointestinal TumorsAnna M Varghese, Dana B Cardin, Jonathan Hersch, et al.
European Radiology|March 7, 2016
Multiparametric MRI in the assessment of response of rectal cancer to neoadjuvant chemoradiotherapy: A comparison of morphological, volumetric and functional MRI parametersAndreas M Hötker, Lisa Tarlinton, Yousef Mazaheri, et al.
Pageof 91